Bridge Neurotech has emerged as a new player in the brain-computer interface sector, backed by $13.5 million in funding. The startup aims to develop a wearable device utilizing ultrasound technology, contrasting with existing solutions that often require surgical implants.
Founded by Will Biederman, who previously contributed to Neuralink's technology, Bridge seeks to create a noninvasive alternative that could broaden access to brain-computer interfaces. The company is initiating its first clinical study in California, focusing on recording brain activity through a small ultrasound probe.